Haemodynamic and clinical effects of ularitide in decompensated heart failureMitrovic V.,
Seferovic P.M.,
Simeunovic D.,
Ristic A.D.,
Miric M.,
Moiseyev V.S.,
Kobalava Z.,
Nitsche K.,
Forssmann W.-G.,
Lüss H.,
Meyer M. capillary wedge pressure (
P=0.052,
P=0.000004,
P=0.000002, respectively) and improved dyspnoea score
Renal effects of ularitide in patients with decompensated heart failure ularitide reduced BUN levels (-4.07 ± 12.30 vs -0.20 ± 7.50 for placebo,
P < .05). Ularitide at 15 and 30 ng